Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke

Davide Seripa, Aldo Dobrina, Maurizio Margaglione, Maria Giovanna Matera, Carolina Gravina, Elena Vecile, Vito Michele Fazio

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Evidence of inflammatory phenomena associated with atherosclerotic plaques is extensive. Interleukin-1 (IL-1) is one of the key modulators of the inflammatory response, and its activity is critically regulated by its receptor antagonist (IL-1Ra). A variable number of tandem repeats (VNTR) in intron 2 of the human IL-1Ra shows a common polymorphism that has been related to different production of IL-1Ra and IL-1 proteins. In monocytes, the less common allele 2 has been associated with an increased production of IL-1Ra and a decreased production of IL-1. Moreover, a cooperative effect with a C to T polymorphism in the promoter of IL-1β gene (C-511→T) has been described. In the present study, we investigated the frequency of these polymorphisms in 110 subjects who survived an ischemic stroke, in 101 healthy age-matched individuals, and in a population-based sample of 1,303 healthy Italians. The frequency of the IL-1Ra 1/1 genotype was significantly higher in stroke survivors with respect to age-matched controls (77.2 and 45.5%, respectively; p <0.001), and to the wide group of healthy Italians (77.2 and 51.9%, respectively; p <0.001). As expected, the estimated frequency of the IL-1Ra allele 1 (Ra*1 allele) in stroke survivors was higher than in age-matched controls (0.851 and 0.664, respectively; p <0.001) and in healthy Italians (0.851 and 0.717, respectively; p <0.001). Thus, ischemic stroke survivors that carry the Ra*1 allele showed a strong association with the disease with respect to age-matched controls [odds ratio (OR) = 3.905; 95% confidence interval (CI), 2.110-7.229] and healthy Italians [OR = 3.256 (95% CI, 1.971-5.379)]. No significant association was seen for the IL-1β (C-511→T) polymorphism. However, in stroke survivors, an association between the Ra*1 allele and the C allele of the IL-1β (-511) polymorphism was found (p <0.001). Our results implicate the IL-1Ra gene in the susceptibility to ischemic stroke, and suggest that IL-1Ra genotyping may be useful in the identification of patient subgroups for pharmacological intervention in IL-1 production or actions.

Original languageEnglish
Pages (from-to)276-281
Number of pages6
JournalCerebrovascular Diseases
Volume15
Issue number4
DOIs
Publication statusPublished - 2003

Fingerprint

Interleukin 1 Receptor Antagonist Protein
Interleukin-1 Receptors
Interleukin-1
Introns
Stroke
Alleles
Survivors
Odds Ratio
Confidence Intervals
Minisatellite Repeats
Atherosclerotic Plaques
Genes
Monocytes
Genotype
Pharmacology

Keywords

  • Atherosclerosis
  • Genetics
  • Interleukins
  • Risk factors
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. / Seripa, Davide; Dobrina, Aldo; Margaglione, Maurizio; Matera, Maria Giovanna; Gravina, Carolina; Vecile, Elena; Fazio, Vito Michele.

In: Cerebrovascular Diseases, Vol. 15, No. 4, 2003, p. 276-281.

Research output: Contribution to journalArticle

Seripa, Davide ; Dobrina, Aldo ; Margaglione, Maurizio ; Matera, Maria Giovanna ; Gravina, Carolina ; Vecile, Elena ; Fazio, Vito Michele. / Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. In: Cerebrovascular Diseases. 2003 ; Vol. 15, No. 4. pp. 276-281.
@article{517cddebb0dc4564b723fae227858dc0,
title = "Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke",
abstract = "Evidence of inflammatory phenomena associated with atherosclerotic plaques is extensive. Interleukin-1 (IL-1) is one of the key modulators of the inflammatory response, and its activity is critically regulated by its receptor antagonist (IL-1Ra). A variable number of tandem repeats (VNTR) in intron 2 of the human IL-1Ra shows a common polymorphism that has been related to different production of IL-1Ra and IL-1 proteins. In monocytes, the less common allele 2 has been associated with an increased production of IL-1Ra and a decreased production of IL-1. Moreover, a cooperative effect with a C to T polymorphism in the promoter of IL-1β gene (C-511→T) has been described. In the present study, we investigated the frequency of these polymorphisms in 110 subjects who survived an ischemic stroke, in 101 healthy age-matched individuals, and in a population-based sample of 1,303 healthy Italians. The frequency of the IL-1Ra 1/1 genotype was significantly higher in stroke survivors with respect to age-matched controls (77.2 and 45.5{\%}, respectively; p <0.001), and to the wide group of healthy Italians (77.2 and 51.9{\%}, respectively; p <0.001). As expected, the estimated frequency of the IL-1Ra allele 1 (Ra*1 allele) in stroke survivors was higher than in age-matched controls (0.851 and 0.664, respectively; p <0.001) and in healthy Italians (0.851 and 0.717, respectively; p <0.001). Thus, ischemic stroke survivors that carry the Ra*1 allele showed a strong association with the disease with respect to age-matched controls [odds ratio (OR) = 3.905; 95{\%} confidence interval (CI), 2.110-7.229] and healthy Italians [OR = 3.256 (95{\%} CI, 1.971-5.379)]. No significant association was seen for the IL-1β (C-511→T) polymorphism. However, in stroke survivors, an association between the Ra*1 allele and the C allele of the IL-1β (-511) polymorphism was found (p <0.001). Our results implicate the IL-1Ra gene in the susceptibility to ischemic stroke, and suggest that IL-1Ra genotyping may be useful in the identification of patient subgroups for pharmacological intervention in IL-1 production or actions.",
keywords = "Atherosclerosis, Genetics, Interleukins, Risk factors, Stroke",
author = "Davide Seripa and Aldo Dobrina and Maurizio Margaglione and Matera, {Maria Giovanna} and Carolina Gravina and Elena Vecile and Fazio, {Vito Michele}",
year = "2003",
doi = "10.1159/000069497",
language = "English",
volume = "15",
pages = "276--281",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke

AU - Seripa, Davide

AU - Dobrina, Aldo

AU - Margaglione, Maurizio

AU - Matera, Maria Giovanna

AU - Gravina, Carolina

AU - Vecile, Elena

AU - Fazio, Vito Michele

PY - 2003

Y1 - 2003

N2 - Evidence of inflammatory phenomena associated with atherosclerotic plaques is extensive. Interleukin-1 (IL-1) is one of the key modulators of the inflammatory response, and its activity is critically regulated by its receptor antagonist (IL-1Ra). A variable number of tandem repeats (VNTR) in intron 2 of the human IL-1Ra shows a common polymorphism that has been related to different production of IL-1Ra and IL-1 proteins. In monocytes, the less common allele 2 has been associated with an increased production of IL-1Ra and a decreased production of IL-1. Moreover, a cooperative effect with a C to T polymorphism in the promoter of IL-1β gene (C-511→T) has been described. In the present study, we investigated the frequency of these polymorphisms in 110 subjects who survived an ischemic stroke, in 101 healthy age-matched individuals, and in a population-based sample of 1,303 healthy Italians. The frequency of the IL-1Ra 1/1 genotype was significantly higher in stroke survivors with respect to age-matched controls (77.2 and 45.5%, respectively; p <0.001), and to the wide group of healthy Italians (77.2 and 51.9%, respectively; p <0.001). As expected, the estimated frequency of the IL-1Ra allele 1 (Ra*1 allele) in stroke survivors was higher than in age-matched controls (0.851 and 0.664, respectively; p <0.001) and in healthy Italians (0.851 and 0.717, respectively; p <0.001). Thus, ischemic stroke survivors that carry the Ra*1 allele showed a strong association with the disease with respect to age-matched controls [odds ratio (OR) = 3.905; 95% confidence interval (CI), 2.110-7.229] and healthy Italians [OR = 3.256 (95% CI, 1.971-5.379)]. No significant association was seen for the IL-1β (C-511→T) polymorphism. However, in stroke survivors, an association between the Ra*1 allele and the C allele of the IL-1β (-511) polymorphism was found (p <0.001). Our results implicate the IL-1Ra gene in the susceptibility to ischemic stroke, and suggest that IL-1Ra genotyping may be useful in the identification of patient subgroups for pharmacological intervention in IL-1 production or actions.

AB - Evidence of inflammatory phenomena associated with atherosclerotic plaques is extensive. Interleukin-1 (IL-1) is one of the key modulators of the inflammatory response, and its activity is critically regulated by its receptor antagonist (IL-1Ra). A variable number of tandem repeats (VNTR) in intron 2 of the human IL-1Ra shows a common polymorphism that has been related to different production of IL-1Ra and IL-1 proteins. In monocytes, the less common allele 2 has been associated with an increased production of IL-1Ra and a decreased production of IL-1. Moreover, a cooperative effect with a C to T polymorphism in the promoter of IL-1β gene (C-511→T) has been described. In the present study, we investigated the frequency of these polymorphisms in 110 subjects who survived an ischemic stroke, in 101 healthy age-matched individuals, and in a population-based sample of 1,303 healthy Italians. The frequency of the IL-1Ra 1/1 genotype was significantly higher in stroke survivors with respect to age-matched controls (77.2 and 45.5%, respectively; p <0.001), and to the wide group of healthy Italians (77.2 and 51.9%, respectively; p <0.001). As expected, the estimated frequency of the IL-1Ra allele 1 (Ra*1 allele) in stroke survivors was higher than in age-matched controls (0.851 and 0.664, respectively; p <0.001) and in healthy Italians (0.851 and 0.717, respectively; p <0.001). Thus, ischemic stroke survivors that carry the Ra*1 allele showed a strong association with the disease with respect to age-matched controls [odds ratio (OR) = 3.905; 95% confidence interval (CI), 2.110-7.229] and healthy Italians [OR = 3.256 (95% CI, 1.971-5.379)]. No significant association was seen for the IL-1β (C-511→T) polymorphism. However, in stroke survivors, an association between the Ra*1 allele and the C allele of the IL-1β (-511) polymorphism was found (p <0.001). Our results implicate the IL-1Ra gene in the susceptibility to ischemic stroke, and suggest that IL-1Ra genotyping may be useful in the identification of patient subgroups for pharmacological intervention in IL-1 production or actions.

KW - Atherosclerosis

KW - Genetics

KW - Interleukins

KW - Risk factors

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0037269189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037269189&partnerID=8YFLogxK

U2 - 10.1159/000069497

DO - 10.1159/000069497

M3 - Article

C2 - 12686792

AN - SCOPUS:0037269189

VL - 15

SP - 276

EP - 281

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 4

ER -